Ken Fisher Fisher Asset Management
AUM
$293B
1-Year Est. Return
28.33%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Fund
S&P 500
1 Year Est. Return
+28.33%
AUM
$293B
AUM Growth
+$16.7B
(+6%)
Holding
1,126
Top Buys
| 1 | +$4.54B | |
| 2 | +$427M | |
| 3 | +$280M | |
| 4 |
NVIDIA
NVDA
|
+$279M |
| 5 |
Microsoft
MSFT
|
+$222M |
Top Sells
| 1 | +$2.04B | |
| 2 | +$1.57B | |
| 3 | +$275M | |
| 4 |
Itaú Unibanco
ITUB
|
+$249M |
| 5 |
Intuit
INTU
|
+$161M |
Sector Composition
| 1 | Technology | 25.35% |
| 2 | Financials | 19.13% |
| 3 | Healthcare | 9.52% |
| 4 | Industrials | 9.41% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Independence Realty Trust
IRT
$3.88B
| $20M | 0.01% |
1,145,635
-56,552
|
|
||
327
BioCryst Pharmaceuticals
BCRX
$1.68B
| $19.2M | 0.01% |
2,467,567
-165,129
|
|
||
328
Revolution Medicines
RVMD
$18.6B
| $19.2M | 0.01% |
241,057
+233,752
|
|
||
329
Berkshire Hathaway Class B
BRK.B
$1.07T
| $19.2M | 0.01% |
38,195
+2,727
|
|
||
330
Oceaneering
OII
$3.31B
| $19.1M | 0.01% |
793,098
+153,214
|
|
||
331
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.35B
| $18.6M | 0.01% |
794,901
+29,695
|
|
||
332
Fluor
FLR
$7.33B
| $18.4M | 0.01% |
463,162
+25,998
|
|
||
333
TechnipFMC
FTI
$24.8B
| $18.2M | 0.01% |
408,437
+27,111
|
|
||
334
Box
BOX
$3.32B
| $18.2M | 0.01% |
607,138
-56,143
|
|
||
335
Merit Medical Systems
MMSI
$4.84B
| $18.1M | 0.01% |
205,003
-16,606
|
|
||
336
Kaiser Aluminum
KALU
$2.28B
| $18M | 0.01% |
157,078
+19,291
|
|
||
337
Freshpet
FRPT
$3.31B
| $18M | 0.01% |
295,712
+7,550
|
|
||
338
Steel Dynamics
STLD
$28B
| $17.8M | 0.01% |
105,083
+70,205
|
|
||
339
BridgeBio Pharma
BBIO
$14.4B
| $17.8M | 0.01% |
+232,401
|
|
||
340
Acadia Pharmaceuticals
ACAD
$3.73B
| $17.8M | 0.01% |
665,087
+26,595
|
|
||
341
SM Energy
SM
$5.11B
| $17.7M | 0.01% |
944,067
+47,735
|
|
||
342
First Financial Bancorp
FFBC
$3.17B
| $17.5M | 0.01% |
699,057
-23,343
|
|
||
343
Materion
MTRN
$3.31B
| $17.4M | 0.01% |
140,265
-8,432
|
|
||
344
ITT
ITT
$17.5B
| $17.4M | 0.01% |
100,449
+37
|
|
||
345
Ovintiv
OVV
$13.3B
| $17.3M | 0.01% |
442,296
-21,145
|
|
||
346
AAR Corp
AIR
$4.47B
| $17.1M | 0.01% |
207,003
+3
|
|
||
347
Prestige Consumer Healthcare
PBH
$3.16B
| $16.9M | 0.01% |
273,885
-19,824
|
|
||
348
Commerce Bancshares
CBSH
$7.9B
| $16.9M | 0.01% |
322,335
+57,941
|
|
||
349
Cal-Maine
CALM
$3.98B
| $16.8M | 0.01% |
211,341
-9,440
|
|
||
350
Church & Dwight Co
CHD
$24.4B
| $16.6M | 0.01% |
198,441
+104,092
|
|